GEODE CAPITAL MANAGEMENT, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$56,062,490
+7.5%
483,235
+8.8%
0.01%
+16.7%
Q2 2023$52,156,124
+51.3%
444,260
+3.2%
0.01%
+50.0%
Q1 2023$34,471,514
+105485.4%
430,571
+4.5%
0.00%
-20.0%
Q4 2022$32,648
-99.9%
412,127
+3.2%
0.01%
+25.0%
Q3 2022$27,828,000
+10.0%
399,262
+3.6%
0.00%0.0%
Q2 2022$25,303,000
+4.1%
385,375
+5.5%
0.00%
+33.3%
Q1 2022$24,306,000
+5.3%
365,290
+10.7%
0.00%0.0%
Q4 2021$23,078,000
+39.2%
329,926
+3.9%
0.00%
+50.0%
Q3 2021$16,582,000
-23.8%
317,608
-0.8%
0.00%
-33.3%
Q2 2021$21,771,000
-1.1%
320,176
+12.0%
0.00%0.0%
Q1 2021$22,020,000
+53.7%
285,833
+19.7%
0.00%
+50.0%
Q4 2020$14,322,000
+59.2%
238,707
+14.2%
0.00%0.0%
Q3 2020$8,994,000
+20.4%
208,941
+15.9%
0.00%0.0%
Q2 2020$7,469,000
+3.5%
180,346
+8.1%
0.00%0.0%
Q1 2020$7,216,000
-55.6%
166,895
-43.1%
0.00%0.0%
Q4 2019$16,256,000
+226.5%
293,566
+104.7%
0.00%
+100.0%
Q3 2019$4,979,000
+3.2%
143,396
+19.7%
0.00%0.0%
Q2 2019$4,823,000
+104.5%
119,767
+67.0%
0.00%0.0%
Q1 2019$2,358,000
-6.4%
71,698
-40.8%
0.00%
Q4 2018$2,518,000
+292.8%
121,206
+232.4%
0.00%
Q3 2018$641,000
+18.3%
36,4660.0%0.00%
Q2 2018$542,00036,4660.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q2 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders